Ethan P Short Md public
[search 0]
More
Download the App!
show episodes
 
Artwork

1
Renegade Psych

Ethan P. Short, MD

Unsubscribe
Unsubscribe
Weekly+
 
In more than a decade of training and clinical practice as a psychiatrist, I've become increasingly disillusioned by the American healthcare system. It prioritizes profit over progress at the expense of OUR health. The average American spends almost twice as much on healthcare as the next highest spending country, yet our life expectancy drags four years behind other industrialized nations and ranks OUTSIDE the top 50 in the world. The system is a disaster, yet it's broadcast as 'the greates ...
  continue reading
 
Loading …
show series
 
In this series, Dr. Stephen Love, MD, and I discuss a vitally important aspect of substance use treatment that is not discussed enough as a society or in our medical training, educating users on how to reduce the harms associated with substance use. We delve into what addiction is in this episode and discuss whether the causes are biological or env…
  continue reading
 
In this series, Dr. Stephen Love, MD, and I discuss a vitally important aspect of substance use treatment that is not discussed enough as a society or in our medical training, educating users on how to reduce the harms associated with substance use. Just as we would not neglect treatment for an uncontrolled diabetic who refuses to comply with diet,…
  continue reading
 
Here, I summarize my closing thoughts, then Adam and I talk about how we fix the systemic and multifactorial problems that in the American healthcare system. As always, to bring my angst down a notch at the end of the series, I've included a local artist and song, again featuring Jared Foos inaugural solo album, Who Loves You Baby, with the song, "…
  continue reading
 
Dr. Urato has been talking about the risks of SSRIs (Prozac, Zoloft, Lexapro, Paxil, etc.) during pregnancy for almost as long as he was talking about the risks of Makena, nearly two decades. He reveals to us the data behind the FACT that there are risks to the developing fetus of maternal SSRI use during pregnancy, starting with the common sense e…
  continue reading
 
In this segment, Dr. Urato and I talk about his history with getting Makena removed from the pharmaceutical market after 20 years and how the pharmaceutical industry rolls out products with a relatively consistent M.O. and playbook. Adam talks about how a lot of treatments don't 'work' from a medical standpoint, but that they 'work' from a financia…
  continue reading
 
For this series, Harvard-trained Dr. Adam Urato, MD, Maternal-Fetal-Medicine specialist joins us to discuss his experiences with Makena, a synthetic progesterone allowed to remain on the market for a convenient 20-year period despite true evidence of its safety and efficacy. His stance established intellectual clout and authority that bolsters his …
  continue reading
 
Welcome to another series. This one features Dr. Adam Urato, MD, a Maternal-Fetal-Medicine specialist living and working in Framingham, MA, near where he trained at Harvard. Adam is in a unique position in medical culture because of his past experience sounding the alarm on Makena, a synthetic progesterone FDA approved for preterm labor in 2013, de…
  continue reading
 
Join us for this episode outlining modern medical training and discussing some of the medicine cultural issues that contribute to a lack of critical thinking, and the primary care shortage, which is the worst in the world, by a landslide. Only 11.5% of U.S. Medical graduates go into primary care, which easily ranks as the lowest in the world (Germa…
  continue reading
 
In this extra segment, recorded with Taylor Beckman, DO, from the "Inherent Problems" series, we discuss how the medical training system exploits students/residents, and acts like a monopoly, paying all residency positions nearly the same amount, with minimal pay increases each year, despite their skill level drastically improving. We give specific…
  continue reading
 
This is the 2nd part of my original recording with Rob Goodknight, my audio engineer and friend, who helped me get the podcast started and provided a studio for our first several recordings. After explaining RFT in the first EXTRA segment, here we turn our focus to outlining the core processes of ACT, Acceptance, Defusion, Mindfulness, Self-as-Cont…
  continue reading
 
So, Rob Goodknight, my audio engineer and friend, helped me get the podcast started and the first several episodes/series were recorded in his studio. This is from one of the first times we ever recorded, and it was just me and Rob talking about RFT, or Relational Frame Theory, the neurolinguistic theory behind the 6 core processes of ACT, or Accep…
  continue reading
 
Hope you enjoyed my conversation with Jim Murphy about his book, Inner Excellence, and its convergence with Acceptance and Commitment Therapy. Here we present some of our closing thoughts, followed by a song, "Found," by Jared Foos, off his inaugural solo album, "Who Loves You Baby." ENJOY and Spread the word about Jared, he's mega-talented and nee…
  continue reading
 
Here, Jim talks about his underlying principles of Inner Excellence. He has taken a lot of core concepts of psychology and sports psychology, and used some of his experience with neurolinguistics to supplement what he has learned, imploring patients to reprogram their subconscious, let go of self-centeredness and be selfless to reduce anxiety, and …
  continue reading
 
Here, Jim and I outline Inner Excellence alongside ACT therapy and the concepts that predecess it. It's so interesting to me that so many of our ideas seem to converge despite coming from drastically different backgrounds. It's also telling that someone who works with high-performance athletes from around the world is utilizing some of the same con…
  continue reading
 
Here, I introduce this series' topic, ACT, through an interview with mental coach, Jim Murphy, whose book, Inner Excellence, and work, has inspired so many to be their best selves. Here, I start out with my typical rant on the topic, followed by a guest introduction and background. Hope you enjoy our conversations. Thanks for listening.  For more s…
  continue reading
 
Here, Dr. Gadh first talks about a necessary step to rectifying the system we currently operate within, in campaign finance reform, and electing conscientious people into positions of power. We then give some of our closing thoughts and wrap up with a mix created by Dr. Gadh's alter ego, DJ Dr. Gadh, titled "Apni Jaise remix," and available on Soun…
  continue reading
 
This is the newest release from RenegadePsych and is on a slightly different topic, ACT therapy. I interview Jim Murphy, a renowned high-performance athletes mental coach who has written an incredibly moving and motivating book, Inner Excellence, summarizing what he has learned in his personal and professional journey. Though he does not have a bac…
  continue reading
 
In this segment, Dr. Gadh and I discuss his research on lithium's effects on reducing COVID infection severity and its' ability to keep our immune responses within the guardrails. He tells us about a co-authored Spanish study in which 14 lithium-treated, COVID-hospitalized patients are compared to 14 non-lithium-treated COVID-hospitalzied patients,…
  continue reading
 
Dr. Gadh and I review his evidence of the benefits of using low doses of lithium to reduce impulsivity that may lead to substance use relapse, as well as the use of low doses of (primarily) stimulants for untreated or undertreated ADHD in the addiction setting. The reality of our current drug epidemic is: WHAT WE'RE DOING IS NOT WORKING. These trea…
  continue reading
 
Here, I rant about the underutilization of lithium and all of its potential benefits, setting the stage for more in-depth conversation and discussion about its array of uses, then introduce Dr. Sudhir Gadh, a New York City psychiatrist who has had tremendous success utilizing low dose lithium in the addiction setting, as well as in his non-addictio…
  continue reading
 
This series is about all of the potential mental and medical benefits of low doses of lithium, featuring New York City psychiatrist and low-dose lithium expert, Dr. Sudhir Gadh, MD. We talk about several potential benefits of low dose lithium, from reducing the risk of suicide, to aiding in detox and addiction recovery, as an antiviral, as a neurop…
  continue reading
 
This episode is from the FIRST TIME I EVER RECORDED, with my friend and audio engineer, Rob Goodknight, a non-medical but curious and inquisitive mind. We talk about some of the same issues I discussed with Dr. Beckman, but in a much more conversational and, at times somewhat crude, manner. I wanted to release this recording, but it really hasn't f…
  continue reading
 
Here, we give some of our closing thoughts and present some generic, system-wide possible solutions to some of the aforementioned problems with our system, as well as some specific methods of fighting over-billing and under-coverage by insurance, to reduce the overall cost of medical bills. Stick around after the disclaimer for a listen to a local …
  continue reading
 
Here, we talk about several examples of over-treatment in our healthcare system. First, Taylor leads the discussion about how heart catheterizations are not necessarily good for everyone with a known blockage in one of their coronary arteries, and provides nuance about STABLE vs UNSTABLE PLAQUES, along with some of the dangers of disrupting unstabl…
  continue reading
 
Here, Taylor and I weave a historical tail of how the United States is trending towards Corporatization of Healthcare in a monopolized system. The old-timey private practice doctor providing quality care to his or her community is being replaced by large systems trying to provide cookie-cutter, one-size-fits-all treatments, and a fast-food drive-th…
  continue reading
 
In this segment, we discuss the high cost of healthcare, both from a systems-perspective, as well as specific cases of patients, personal contacts, and our own medical bills. It's kind of crazy that we spend nearly twice as much per person on healthcare as THE NEXT HIGHEST HEALTHCARE SPENDING COUNTRY IN THE WORLD. You would expect that means we hav…
  continue reading
 
This episode starts out with a typical monologue intro rant about some of the Inherent Problems in U.S. Healthcare. Then, we transition into learning more about our guest, Dr. Taylor Beckman, DO, who will finish his residency training in June and start on a cardiology fellowship in July. We talk about the issues with the horrifically high (and only…
  continue reading
 
This is the teaser for the upcoming series on inherent problems in U.S. healthcare, where we'll talk about the absurd costs of our healthcare, the trend towards Corporatization of healthcare, and some other major pitfalls of the American medical system. My guest on this series is Dr. Taylor Beckman, a 3rd-year internal medicine resident at The Univ…
  continue reading
 
I surprised myself on this one with a vicious rant about Makena, a synthetic intramuscular drug FDA approved in 2003 for preterm labor that was recently recalled in 2023. I get pretty elevated in my 8-minute rant introducing this segment and talking about the implications of the Makena catastrophe. Other than that, we talk about other failed treatm…
  continue reading
 
Here, we each present our closing thoughts on the use of female reproductive hormones during menopause and the phenomenon of menopausal psychosis and/or exacerbation of psychiatric symptoms during female hormonal transitional periods. Thanks so much to Drs. Wood and Grider for being a part of this, and please stick around after the disclaimer to he…
  continue reading
 
In this segment, Dr. Wood and I reveal what we know about the exacerbation of psychotic symptoms in female patients with known schizophrenia or bipolar disorder during hormonal transitional periods, including menopause, postpartum, and monthly menstrual cycles. It adds to the common sense evidence of the importance of considering the role of estrog…
  continue reading
 
In this segment, Drs. Wood, Grider, and I discuss the flaws of the large NIH-sponsored Women's Health Initiative (WHI) Study that was intended to provide more clarity on the role of hormones during female transitional periods and its impact on the use of female reproductive hormones after 2002. The WHI was a 10+ year endeavor studying thousands upo…
  continue reading
 
In this segment, I start out by providing a history of hormone discovery and using hormones as treatment. Dr. Grider gives us a basic explanation of what menopause is, including typical patient presentations, symptoms, and the relationship to fluctuating reproductive hormone levels. And Dr. Wood tells us what to expect with peri-menopausal psychosi…
  continue reading
 
In this segment, Jenny and I discuss our cases involving first episode of psychosis in menopause, as well as our differential diagnosis for this phenomenon. While there simply isn't enough research on this specific presentation, it seems to be common sense that trying hormones to alleviate symptoms would be a much safer and possibly more effective …
  continue reading
 
Hey everyone, join us for the intro to our upcoming series on the role of female reproductive hormones, such as estrogen and progesterone, on women's health, especially during times of transition, such as menopause, postpartum, or monthly cycles. The title centers around clinical experiences with women having their first episode of psychosis and in…
  continue reading
 
Hey everyone, join us for our teaser for the upcoming series on the role of female reproductive hormones, such as estrogen and progesterone, on women's health. The title centers around clinical experiences with women having their first episode of psychosis and inpatient psychiatric hospitalization during menopause and I am joined by my friend and c…
  continue reading
 
This extra segment involves a nuanced discussion about the role of long-term benzodiazepine use in the ability to learn and the risk of dementia. We know that Alcohol causes a specific type of dementia, but, despite their similarities in mechanism of action, don't regularly talk about Benzodiazepines carrying the same risk. Hope you enjoyed listeni…
  continue reading
 
Michael and I give our closing thoughts and recommendations on benzodiazepine use. In summary, while benzo's have many appropriate uses, there is no good data to promote long-term regular use of benzodiazepines for anxiety or other conditions, Use Xanax/Alprazolam for Xanax/Alprazolam withdrawal (other benzo's will provide incomplete coverage of th…
  continue reading
 
-Here, we start off with a discussion about why the question of whether someone with long-term benzo use and abrupt discontinuation experiences symptoms of benzo withdrawal or if those represent rebound symptoms of the original anxiety or panic. If you're on a benzo (or any other powerful neurotransmitter-altering substance, for that matter) for lo…
  continue reading
 
This segment includes one of the most important and under-recognized phenomena when it comes to benzo withdrawal... that Xanax, or Alprazolam, has a unique chemical structure that makes its' withdrawal resistant to other benzo's. In other words, patients in Xanax withdrawal can present to the hospital with Altered Mental Status and possibly convuls…
  continue reading
 
Here, Michael and I go back to the origins of benzodiazepines, the cultural factors that increased their popularity in the United States, the evolution of what drug class they have belonged to over time (named, of course, by pharmaceutical marketing divisions), and surmise about what 'new' classes of drugs might replace them. We then give a basic e…
  continue reading
 
Here, Michael and I reveal several historical, and more recent, statistics and common-sense findings regarding the dangers of benzodiazepines. It is so explicit to us that, while this class of medications does have several beneficial short-term uses, the longer-term uses of benzodiazepines undoubtedly do more harm than good. Benzo's combined with o…
  continue reading
 
Per usual, in this first episode of the series, I give my rant on the subject of benzodiazepines, followed by an introduction to our repeat guest for this series, Michael Shuman, a clinical pharmacist with expertise in psychopharmacology. Benzo's include medications such as Xanax, Valium, Klonopin, and Ativan. Join us as we discuss historical trend…
  continue reading
 
In this month's series, we're talking about Benzodiazepines, or Benzo's, which include medications like Xanax, Valium, Klonopin, and Ativan, among others. Joining me for the 2nd time in this series is Michael Shuman, PharmD. In the segments that follow, we'll discuss historical trends in benzo prescribing and use, appropriate and inappropriate uses…
  continue reading
 
Dr. Healy and I discuss how providers can navigate the current system we operate in, and offer our closing thoughts on the series. What follows is the most uplifting part of this entire series and one of my favorite songs by a local Louisville artist that we've included in the podcast thus far, "Roses" by 'Nolia Noon.' I hope you enjoy. You can fin…
  continue reading
 
Enjoy this extra segment that didn't fit into the main topic on SSRIs, but is very interesting and relevant to current times. First, we talk about the potential benefits and pitfalls of using Artificial Intelligence in medicine. Then, a brief question about Dr. Healy's exposure to Robert F. Kennedy's platform leads to another interesting story abou…
  continue reading
 
Dr. Healy talks about trends in falling life expectancy (worst in the US of developed nations) and relates it to being over-medicated, or poly-pharmacy. He emphasizes the importance of listening to your patients, educating them on the untoward effects of being on too many medications, and involving them in the decision-making process. This clinical…
  continue reading
 
Dr. Healy tells us how the industry's commanding influence over medical literature has allowed them to create guidelines and take over clinical practice at the extreme detriment of people's health. They use Randomized Controlled Trials as a gold-standard and a crutch to justify stating medications work and de-legitimize any anectdotal experiences f…
  continue reading
 
In 1987, roughly 0.2% of American kids were taking psychiatric medications. Now, over 15% are taking psych meds, with some estimates much higher than that; the majority of these are SSRIs. Dr. Healy gives us the inside scoop on how companies like Pfizer and GlaxoSmithKline manipulate data for FDA approval and wonders what the effects of so many SSR…
  continue reading
 
Loading …

Quick Reference Guide